5th March 2019
- 0 comments
AdoRx Therapeutics, a UK based drug discovery company, has announced that it has entered into a strategic collaboration with Johnson & Johnson Innovation LLC* and the Lung Cancer Initiative at Johnson & Johnson to develop novel therapeutics for the treatment of lung cancer.
...In order to read the full story we need you to be registered with us, please click the links below to login or register.